key: cord-0929494-r2afj4eo authors: Nasiri, Kaveh; Dimitrova, Aleksandra; Wrbas, Karl-Thomas title: Managing halitosis during the SARS-CoV-2 pandemic date: 2022-05-02 journal: J Dent Sci DOI: 10.1016/j.jds.2022.04.020 sha: 135497679dc4413de48387e17674ece2ee01e420 doc_id: 929494 cord_uid: r2afj4eo nan On December 31, 2019, the world health organization reported pneumonia of an unknown cause in Wuhan, China. Later, coronavirus was identified as a respiratory disease cause. It was announced as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Due to the specific structure of spike protein, the virus has a high mutation potential. Among the virus's mutations, the last two mutations, namely Delta (B. 1 Halitosis is a term that refers to foul odor caused by a multifactorial etiology. This disorder can affect the quality of life due to its multiple social and psychological effects. Of several classifications proposed regarding halitosis, two ones can be highlighted during the pandemic: 1) intra-oral (i.e., blood-borne) and 2) extra-oral (i.e., non-blood borne) halitosis. The intraoral halitosis is caused by oral diseases such as gingivitis, periodontitis, pericoronitis, dental caries, and oral ulceration. A variety of diseases, including diabetic metabolic disorders, kidney and liver diseases, specific medicines, and food, can cause blood-borne halitosis. In comparison, non-blood-borne halitosis is caused by respiratory and gastrointestinal diseases. 2, 3 In a review study, Wu et al. reported the prevalence of halitosis in different countries and age groups as follows: 1) The prevalence of halitosis was 24% among Polish university students; 2) in the USA, dentists diagnosed 41% of their patients' halitosis in the first week; 3) in Korea, Sweden, and Brazil, the prevalence of halitosis among adolescents was 25%; 4) halitosis in 12-year-old children in the USA was 37.6%. It has been reported that one in four days. In the case of refractory H. pylori infection, bismuth therapy is recommended. 7 The efficacy of lemon essential oil (LEO) and other mouthwashes in treating halitosis was also investigated. To this end, 48 volunteers (i.e., 20 males and 28 females without systematic diseases) with more than 180 ppb of volatile sulfur compound, detected through Halimeter and positive organoleptic test (i.e., >1), were included in the study. The results showed that LEO has satisfactory effectiveness in reducing halitosis compared to 0.1% cetylpyridinium chloride, 3% hydrogen peroxide (H2O2), and distilled water (H2O) as the control group. The inhibitory effects of LEO concentration were as follows: 1) 9 mg/ml, 4.5 mg/ml, and 2.25 mg/ml had an effect against salivary bacteria; 2) 0.563 mg/ml to 4.5 mg/ml had an effect against biofilm formation of salivary bacteria; 3) 0.563 mg/ml to 2.25 mg/ml had an effect against the volatile sulfur compound. Therefore, using LEO during the pandemic can be considered to reduce the severity of halitosis. 8 Another study evaluated the treatment of halitosis through photodynamic therapy in older patients with complete dentures. In this research, 40 patients older than 60 years with halitosis J o u r n a l P r e -p r o o f (H2S concentration>112 ppb) were divided into two groups. The first and second groups (n=20) were treated with a tongue scraper and antimicrobial photodynamic therapy (aPDT), respectively. The H2S results in both groups were as follows: Group 1 (treated with a tongue scraper): 736.7 ppb (initially), 185.3 ppb (after treatment), and 218.2 ppb (a 7-day follow-up). Group 2 (treated with aPDT): 698.7 ppb (initially), 18.5 ppb (after treatment), and 39.0 (a 7day follow-up). The aPDT showed a lower concentration of H2S compared with tongue scraper treatment. Therefore, it can be considered for treating halitosis, particularly in the older population. 9 It was also reported that Lacer Hali TM could be used as an alternative to chlorhexidine based toothpaste and mouthwashes for the management of halitosis. 10 Based on the information provided in this letter, individuals might abstain from wearing face masks due to halitosis. Hence, to minimize the spread of COVID-19, clinicians should highlight the etiology, diagnosis, appropriate treatment, and management of halitosis. J o u r n a l P r e -p r o o f Omicron variant in the current SARS-CoV-2 pandemic Halitosis: prevalence, risk factors, sources, measurement and treatment -a review of the literature The role of oral microbiota in intra-oral halitosis Halitosis in COVID-19 patients Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population Salivary β-glucosidase as a direct factor influencing the occurrence of halitosis Treatment of refractory helicobacter pylori infection-tailored or empirical therapy Effect of lemon essential oil on halitosis Treatment of halitosis with photodynamic therapy in older adults with complete dentures: a randomized, controlled, clinical trial Evaluation of the efficacy of lacer Hali TM treatment on the management of halitosis: a randomized double-blind clinical trial This brief letter has not been published. We guarantee that no intentional or unintentional plagiarism has occurred. We also confirm that all figures and tables are original and created by the authors of this study. I attest to the fact that all authors listed on the title page have read the manuscript, attest to the validity and legitimacy of the data and its interpretation, and agree to its submission to Journal of Dental Sciences. We have no conflicts of interest.